This article is more than 5 years old. Information may no longer be current.

FDA approves phenylephrine hydrochloride solution to dilate pupil

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Phenylephrine hydrochloride ophthalmic solution USP 2.5% and 10% has been approved by the U.S. Food and Drug Administration, Paragon BioTeck announced in a news release.

The solution, an alpha-1 adrenergic receptor agonist used to dilate the pupil, has been marketed for decades without FDA approval, the release said. The approval ensures it is safe and manufactured with proper oversight.

The 2.5% solution is intended for topical use in patients younger than 1 year or those with hypertension or thyrotoxicosis. The 10% solution can be used topically in all other patients, the release said.